American Policy Roundtable Logo
Bookmark and Share


For the Common Good
By David Zanotti

Up in Smoke

The Philosophy of Science and Medicine
By Dr. Charles McGowen

Affordable Care, Atheism and Astrophysics

A Moment in History
By Dr. Jeff Sanders

Darkest Hour

The Public Square The Latest on
The Public Square

2 Minute Format Archive

The Politics of Shame
January 19, 2018
60 Minute Format Archive

Sign up for the
Roundtable eNewsletter
Embryonic Stem Cell Research

What's the issue?

Embryonic stem cell research just doesn’t work for several reasons.

One of the best arguments on embryonic stem cell research is rejection. When you put foreign DNA into the human body, the immune system just won’t accept it. That’s a huge obstacle researchers have to overcome, and they haven't yet, which makes the advantages of embryonic stem cell research very, very minimal.

Secondly, researchers are having a very difficult time getting embryonic stem cells to do what they want them to do. They need many more tests, which means the destruction of thousands of human embryos.

Does this mean we don't want to find the cure Alzheimers? Absolutely not.

Adult stem cell research makes sense. It requires no killing of a human life and using cells that are readily available to work to create new cell growth and cures. To date ASCR has created numerous promising cures.

If you remember, all the benefits of embryonic stem cell research that was proclaimed by South Korean doctors - was a lie.


President Obama lifts restrictions on federal funding for human embryonic stem cell research.

On August 9, 2001 President George W. Bush announced that federal funds may be awarded for research using human embryonic stem cells with the following restrictions:

  • The stem cell lines must have been in existence prior to Aug. 9, 2001
  • The stem cells must have been derived from an embryo that was created for reproductive purposes and no longer needed.
  • Informed consent must have been granted for the donation of the embryo and that donation must not have involved financial incentives.

At that time this executive decisions caused serious concern based on the fact that, in order to harvest human embryonic stem cells, human life would be destroyed. On the other hand, the medical advances in stem cell research using adult stem cells, cord blood stem cells, or autologous cells derived from the patient's own stem cells have produced very promising results, without the destruction of human life.

Restrictions placed on the federal funding by former President Bush did nothing to prevent unlimited experimentation with human embryos with the use of state or private funds. States which have provided funding for this type of research include California, Connecticut, Illinois, Maryland, New Jersey, New York and Wisconsin.

It is important to understand that, even with the few restrictions placed on federal funding of human embryonic stem cell research, this type of work has largely been able to proceed

President Obama's reversal: On March 9 2009 President Obama signed Executive Order 13505 lifting the restrictions on the use of federal funds for human embryonic stem cell research. It stated, in part, "For the past 8 years, the authority of the Department of Health and Human Services, including the National Institutes of Health, to fund and conduct human embryonic stem cell research has been limited by Presidential actions. The purpose of this order is to remove these limitations on scientific inquiry, to expand NIH support for the exploration of human stem cell research..."

The floodgates on federal funding for the controversial embryonic stem cell research are now open.

As a physician specializing in Internal Medicine, Dr. Chuck McGowan clarified some misconceptions regarding stem cell research. "Eight nations have abandoned embryonic stem cells because they failed to produce acceptable results and moved in favor of using the patient's own stem cells (called autologous, or self derived) because they afford a plentiful supply of immunologically compatible stem cells; thus also obviating rejection phenomena associated with adult (cord blood and amniotic fluid derived), homologous stem cells. There have been successes in spinal cord injuries (Portugal), Type I diabetes (Brazil), bladder incontinence (Austria), heart disease (Germany, Norway, Thailand, Israel, and Singapore) and a potentially fatal congenital skin disease (Italy).

Additional links:
President Obama's executive order no. 13505, March 9, 2009

New York Times, "Rethink Stem Cells, Science Already Has"


More arguments against embryonic stem cell research